Your browser doesn't support javascript.
loading
A Comprehensive Functional Analysis of NTRK1 Missense Mutations Causing Hereditary Sensory and Autonomic Neuropathy Type IV (HSAN IV).
Shaikh, Samiha S; Chen, Ya-Chun; Halsall, Sally-Anne; Nahorski, Michael S; Omoto, Kiyoyuki; Young, Gareth T; Phelan, Anne; Woods, Christopher Geoffrey.
Afiliação
  • Shaikh SS; Cambridge Institute for Medical Research, University of Cambridge, Cambridge, CB2 0XY, UK.
  • Chen YC; Cambridge Institute for Medical Research, University of Cambridge, Cambridge, CB2 0XY, UK.
  • Halsall SA; Molecular Genetics Laboratory, Addenbrooke's Hospital, Cambridge, UK.
  • Nahorski MS; Cambridge Institute for Medical Research, University of Cambridge, Cambridge, CB2 0XY, UK.
  • Omoto K; Neuroscience and Pain Research Unit, Pfizer Ltd, Great Abington, UK.
  • Young GT; Neuroscience and Pain Research Unit, Pfizer Ltd, Great Abington, UK.
  • Phelan A; Stratified Medical, London, NW1 1LW, UK.
  • Woods CG; Cambridge Institute for Medical Research, University of Cambridge, Cambridge, CB2 0XY, UK.
Hum Mutat ; 38(1): 55-63, 2017 01.
Article em En | MEDLINE | ID: mdl-27676246
ABSTRACT
Hereditary sensory and autonomic neuropathy type IV (HSAN IV) is an autosomal recessive disorder characterized by a complete lack of pain perception and anhidrosis. Here, we studied a cohort of seven patients with HSAN IV and describe a comprehensive functional analysis of seven novel NTRK1 missense mutations, c.1550G >A, c.1565G >A, c.1970T >C, c.2096T >C, c.2254T >A, c.2288G >C, and c.2311C >T, corresponding to p.G517E, p.G522E, p.L657P, p.I699T, p.C752S, p.C763S, and p.R771C, all of which were predicted pathogenic by in silico analysis. The results allowed us to assess the pathogenicity of each mutation and to gain novel insights into tropomyosin receptor kinase A (TRKA) downstream signaling. Each mutation was systematically analyzed for TRKA glycosylation states, intracellular and cell membrane expression patterns, nerve growth factor stimulated TRKA autophosphorylation, TRKA-Y496 phosphorylation, PLCγ activity, and neurite outgrowth. We showed a diverse range of functional effects one mutation appeared fully functional, another had partial activity in all assays, one mutation affected only the PLCγ pathway and four mutations were proved null in all assays. Thus, we conclude that complete abolition of TRKA kinase activity is not the only pathogenic mechanism underlying HSAN IV. By corollary, the assessment of the clinical pathogenicity of HSAN IV mutations is more complex than initially predicted and requires a multifaceted approach.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neuropatias Hereditárias Sensoriais e Autônomas / Mutação de Sentido Incorreto / Receptor trkA Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Hum Mutat Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neuropatias Hereditárias Sensoriais e Autônomas / Mutação de Sentido Incorreto / Receptor trkA Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Humans Idioma: En Revista: Hum Mutat Ano de publicação: 2017 Tipo de documento: Article